It can increase the risk of kidney damage or pancreatitis While rare , tirzepatide has been associated with serious side effects, including acute pancreatitis (inflammation of the pancreas) or kidney injury
And most importantly, it requires understanding what your body is about to go through, because the research on what happens after stopping tirzepatide is sobering
Semaglutide is only FDA-approved for individuals who are overweight or have obesity and have at least one weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes
Each unit on the syringe represents just 0.05mg of tirzepatide
Another study, not yet published, is SURMOUNT-OSA, a clinical trial of 52-weeks that examined the efficacy and safety of TZP versus placebo in obese participants and an established OSA diagnosis for treatment of moderate and severe OSA (102)